- Home
- Respiratory Medicine
- Nerandomilast Use In IPF: A Clinical Case Highlighting Slowed Disease Progression

2mo3 min read
Medical Article
Introduction Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease, with a mortality rate exceeding that of several types of cancers (1). Although its pathogenesis is not yet fully understood, it is generally recognized that repeated epithelial cell injuries in predisposed individuals are a key driver of the disease (1). These inju

Nerandomilast Use In IPF: A Clinical Case Highlighting Slowed Disease Progression
12 Reached
Similar Content

Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments

Woman presented with Fever of Unknown Origin
7724 Reached93 Comments19 Likes

Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes

Case of Pulmonary Embolism with Syncope
544 Reached4 Likes

Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes